| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/20/2013 | CN102935202A Traditional Chinese medicine preparation for treating depressive disorder and preparation process |
| 02/20/2013 | CN102935191A Medicine for ischialgia and method for preparing medicine for ischialgia |
| 02/20/2013 | CN102935185A Pills for treating neurasthenia and preparation method |
| 02/20/2013 | CN102935180A Traditional Chinese medicinal preparation for treating headache |
| 02/20/2013 | CN102935167A Chinese medicament for treating abdominal epilepsy syndrome |
| 02/20/2013 | CN102935100A Preparation method and applications of queen lagerstroemia folium apocyni veneti general flavones |
| 02/20/2013 | CN102935074A Trazodone hydrochloride osmotic pump controlled release tablet |
| 02/20/2013 | CN102935071A Venlafaxine hydrochloride controlled-release pellet and preparation method thereof |
| 02/20/2013 | CN102175682B Bioactivity detection method and application of recombined humanized neuroglobin |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/20/2013 | CN102046164B Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
| 02/20/2013 | CN102038952B Composition for improving the viability of nerve cells and use of the composition |
| 02/20/2013 | CN101987094B Ornithine aspartate injection and preparation method thereof |
| 02/20/2013 | CN101351451B Multicyclic amino acid derivatives and methods of their use |
| 02/19/2013 | US8378118 Pyrazole-based thyroid receptor compounds |
| 02/19/2013 | US8378112 Glycyrrhetinic acid derivative and use thereof |
| 02/19/2013 | US8378108 Apoptosis signal-regulating kinase inhibitors |
| 02/19/2013 | US8378070 Peptides for the regulation of neurotransmitter sequestration and release |
| 02/19/2013 | US8377968 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 02/19/2013 | US8377959 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377944 Thienopyrimidine derivatives |
| 02/19/2013 | US8377931 Benzoxazine derivatives and uses thereof |
| 02/19/2013 | US8377929 Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same |
| 02/19/2013 | US8377885 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| 02/19/2013 | US8377875 Therapeutics based on tau/microtubule dynamics |
| 02/19/2013 | US8377692 Process for the manufacturing of human mononuclear phagocytic leukocytes |
| 02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
| 02/19/2013 | US8377479 Compositions and methods for delivery of poorly soluble drugs |
| 02/19/2013 | US8377456 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 02/19/2013 | CA2694881C The application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression |
| 02/19/2013 | CA2560256C Heteroaryl piperidine glycine transporter inhibitors |
| 02/19/2013 | CA2547820C (s)-2-n-propylamino-5-hydroxytetralin as a d3 agonist |
| 02/19/2013 | CA2508657C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/19/2013 | CA2469092C Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als) |
| 02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
| 02/14/2013 | WO2013023104A1 Chlorobis copper (i) complex compositions and methods of manufacture and use |
| 02/14/2013 | WO2013023102A1 Inhibiting transient receptor potential ion channel trpa1 |
| 02/14/2013 | WO2013022972A1 Methods of treating progressive forms of multiple sclerosis |
| 02/14/2013 | WO2013022717A1 Pure filamentous bacteriophage and methods of producing same |
| 02/14/2013 | WO2013022139A1 Method for treatment of diseases caused by accumulation of beta-amyloids in brain parenchyma with low concentration thiazolidinedione derivatives |
| 02/14/2013 | WO2013022079A1 Method for treating schizophrenia |
| 02/14/2013 | WO2013021353A1 Surface modified proteinaceous spherical particles and uses thereof |
| 02/14/2013 | WO2013020992A1 Dihydrothienopyrimidines |
| 02/14/2013 | WO2013020966A1 Treatment of neurodegenerative diseases |
| 02/14/2013 | WO2013020930A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/14/2013 | WO2013020914A1 Peg-conjugated peptides |
| 02/14/2013 | WO2013020909A1 Materials and methods for the treatment of tauopathies |
| 02/14/2013 | WO2013020724A1 Composition comprising a tlr agonist and an antibody specific for an antigen and uses thereof as vaccine |
| 02/14/2013 | WO2013020723A1 Compositions and uses thereof for the treatment or prevention of alzheimer's disease |
| 02/14/2013 | WO2013020722A2 Compositions and uses |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | WO2013020368A1 Rhodiola rosea extracts and isolated compounds and uses thereof for treating neurodegenerative diseases |
| 02/14/2013 | WO2013020229A1 Tetrahydroprotoberbine compounds and uses thereof in the treatment of neurological, psychiatric and neurodegenerative diseases |
| 02/14/2013 | WO2012134897A8 Treatment of sensory disturbance disorders |
| 02/14/2013 | WO2012107708A9 Administration regime for nitrocatechols |
| 02/14/2013 | WO2012025237A9 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041040 Solid pharmaceutical composition for buccal administration of agomelatine |
| 02/14/2013 | US20130041037 Therapeutic applications of fatty acid amide hydrolase inhibitors |
| 02/14/2013 | US20130041028 Methods of using (1s,3s)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid |
| 02/14/2013 | US20130041026 Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use |
| 02/14/2013 | US20130041021 Methods of improving the pharmacokinetics of doxepin |
| 02/14/2013 | US20130041008 Compounds for enzyme inhibition |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130041000 Novel azole compound |
| 02/14/2013 | US20130040997 Novel pyridine carboxylic acid based compound used as a p2x1 and p2x3 receptor antagonist, a production method for the same and a composition comprising the same |
| 02/14/2013 | US20130040994 Methods of Treatment Using Allosteric Processing Inhibitors for Matrix Metalloproteinases |
| 02/14/2013 | US20130040992 Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective Ligands |
| 02/14/2013 | US20130040986 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 02/14/2013 | US20130040985 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/14/2013 | US20130040982 Oral sustained release formulation of huperzine a |
| 02/14/2013 | US20130040978 Spiro isoxazoline compounds as sstr5 antagonists |
| 02/14/2013 | US20130040977 Pro-Neurogenic Compounds |
| 02/14/2013 | US20130040976 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/14/2013 | US20130040971 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040966 Pharmaceutical formulations containing dopamine receptor ligands |
| 02/14/2013 | US20130040959 Heterocyclic Quinolizine Derived M1 Receptor Positive Allosteric Modulators |
| 02/14/2013 | US20130040957 Deuterium-Enriched Pyrimidine Compounds and Derivatives |
| 02/14/2013 | US20130040955 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040950 Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/14/2013 | US20130040948 Novel benzodioxole piperazine compounds |
| 02/14/2013 | US20130040947 Trkb agonists and methods of use |
| 02/14/2013 | US20130040944 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 02/14/2013 | US20130040940 Mercaptoamidine derivatives and methods of use |
| 02/14/2013 | US20130040939 Oral Suspension Formulations of Esclicarbazepine Acetate |
| 02/14/2013 | US20130040938 Compositiions for treating cognitive disorders |
| 02/14/2013 | US20130040936 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 02/14/2013 | US20130040933 Azaindoles as janus kinase inhibitors |
| 02/14/2013 | US20130040932 Substituted aryl sulfone derivatives as calcium channel blockers |
| 02/14/2013 | US20130040931 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use |
| 02/14/2013 | US20130040930 Novel amide derivative and use thereof as medicine |
| 02/14/2013 | US20130040920 Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol |
| 02/14/2013 | US20130040916 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/14/2013 | US20130040912 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders |
| 02/14/2013 | US20130040908 Substitution derivatives of n6-benzyladenosine-5' -monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds |
| 02/14/2013 | US20130040903 Pharmaceutical compositions for treating depression and anxiety |
| 02/14/2013 | US20130040003 Natural - topical analgesic and anti-inflammatory composition |
| 02/14/2013 | US20130040002 Anti-oxidant herbal composition |
| 02/14/2013 | US20130039998 Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorder |